Alternative neutralising target24 Jul 2020 12:42
RSV is another respiratory virus - causes significant problems especially in premature infants. Synergis has been used. Thus paper highlights a more potent neutralising therapy. Would be a less competitive space but given how many babies are born per year 800K in UK....